SX8

6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline

Find entries where: SX8

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline
Identifiers	6-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[5,4-f]pyridazin-3-yl]sulfanyl]quinoline
Formula	C₁₈ H₁₃ N₇ S
Molecular Weight	359.408
Type	NON-POLYMER
Isomeric SMILES	Cn1cc(cn1)c2ccc3nnc(n3n2)Sc4ccc5c(c4)cccn5
InChI	InChI=1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3
InChIKey	BCZUAADEACICHN-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	39
Chiral Atom Count	0
Bond Count	43
Aromatic Bond Count	27

Drug Info: DrugBank

DrugBank ID	DB06314
Name	SGX-523
Groups	investigational
Description	A MET receptor tyrosine kinase inhibitor.
Synonyms	6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline SGX-523
Indication	Investigated for use/treatment in solid tumors and cancer/tumors (unspecified).
CAS number	1022150-57-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Hepatocyte growth factor receptor	MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAET...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682